SULFANILAMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sulfanilamide, and when can generic versions of Sulfanilamide launch?
Sulfanilamide is a drug marketed by Cosette and is included in one NDA.
The generic ingredient in SULFANILAMIDE is sulfanilamide. There are six drug master file entries for this compound. Additional details are available on the sulfanilamide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SULFANILAMIDE?
- What are the global sales for SULFANILAMIDE?
- What is Average Wholesale Price for SULFANILAMIDE?
Summary for SULFANILAMIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 174 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,465 |
| DailyMed Link: | SULFANILAMIDE at DailyMed |
Recent Clinical Trials for SULFANILAMIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Peking University First Hospital | Phase 4 |
| Beijing Chao Yang Hospital | Phase 4 |
| Shanxi Dayi Hospital | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for SULFANILAMIDE
US Patents and Regulatory Information for SULFANILAMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cosette | SULFANILAMIDE | sulfanilamide | CREAM;VAGINAL | 088718-001 | Sep 19, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
